miRNAs and NFKB1 and TRAF6 target genes: The initial functional study in CD14+ monocytes in rheumatoid arthritis patients
Open Access
- 1 January 2024
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 47 (2) , e20230235
Abstract
We predicted miRNAs with regulatory impact on NFKB1 and TRAF6 gene expression and selected the miR-194-5p, miR-124-3p, miR-9-5p, and miR-340-5p and their target genes for expression analyses on CD14+ monocytes from rheumatoid arthritis (RA) patients and healthy controls. Additionally, we evaluated the influence of genes and miRNA expression on RA patients’ cytokine levels. No difference was observed in genes or miRNAs expression when compared to healthy controls and RA patients or clinical parameters. However, we found a significant difference between miR-194-5p and miR-9-5p levels (FC=-2.31; p=0.031; FC=-3.05;p=0.031, respectively) and non-prednisone users as compared to prednisone using patients. We conducted correlation analyses to identify the strength of the relationship between expression data and cytokine plasma levels. We observed a moderate positive correlation between miR-124-3p expression and IL-6 plasma levels (r=0.46; p=0.033). In addition, overexpression of miRNAs was concomitant to TRAF6 and NFKB1 genes as indicated by correlation analyses: TRAF6 and miR-194-5p (r=0.60;pNFKB1 and miR-194-5p (r=0.72;pNFKB1 and TRAF6 genes and miRNAs monocyte expression do not appear to be related to RA but showed a significant difference in different groups of RA therapy. In addition, increased levels of miRNAs can be linked to concomitant overexpression of TRAF6 and NFKB1 in monocytes and act as its regulators.Keywords
This publication has 46 references indexed in Scilit:
- The lncRNA ROR/miR-124-3p/TRAF6 axis regulated the ischaemia reperfusion injury-induced inflammatory response in human cardiac myocytesJournal of Bioenergetics and Biomembranes, 2019
- Analysis of miRNA expression in patients with rheumatoid arthritis during remission and relapse after a 5-year trial of tofacitinib treatmentInternational Immunopharmacology, 2018
- Rheumatoid arthritisNature Reviews Disease Primers, 2018
- Tumor necrosis factor receptor-associated factor (TRAF) 6 inhibition mitigates the pro-inflammatory roles and proliferation of rheumatoid arthritis fibroblast-like synoviocytesCytokine, 2017
- microRNA-124 negatively regulates TLR signaling in alveolar macrophages in response to mycobacterial infectionMolecular Immunology, 2014
- Regulation of nuclear factor-κB in autoimmunityTrends in Immunology, 2013
- Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expressionJournal of Autoimmunity, 2013
- Posttranscriptional Upregulation by MicroRNAsWIREs RNA, 2011
- CD11c as a Transcriptional Biomarker to Predict Response to Anti-TNF Monotherapy With Adalimumab in Patients With Rheumatoid ArthritisClinical Pharmacology & Therapeutics, 2009
- Combinatorial microRNA target predictionsNature Genetics, 2005